Paul Matteis

Stock Analyst at Stifel

(0.63)
# 2437
Out of 5,372 analysts
140
Total ratings
33.93%
Success rate
-5.02%
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
78 94
61.97 51.69% 2 May 29, 2025
VIGL Vigil Neuroscience
Downgrades: Hold
11 8
7.87 1.65% 2 May 28, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
300 345
308.84 11.71% 13 Mar 31, 2025
NMRA Neumora Therapeutics
Downgrades: Hold
6 2
0.79 153.16% 2 Mar 7, 2025
SION Sionna Therapeutics
Initiates Coverage On: Buy
32
13.95 129.39% 1 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
4.49 144.99% 1 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
18 32
11.97 167.34% 2 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
490 494
442.29 11.69% 18 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 32
14.78 116.51% 1 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
10 6
9.11 -34.14% 5 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4
1.53 161.44% 4 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
2.24 346.43% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 60
18.4 226.09% 2 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
25 36
29.75 21.01% 7 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
115 87
55.01 58.15% 8 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 66
10.86 507.73% 3 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
11 218.18% 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 53
36.17 46.53% 5 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 21
22.83 -8.02% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
3.92 639.8% 1 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
141 144
124.84 15.35% 8 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
315 287
126.62 126.66% 6 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
3.9 412.82% 1 Nov 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
2.36 408.47% 1 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24
1.4 1614.29% 2 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
260 295
n/a n/a 4 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
50 54
n/a n/a 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
36 5
n/a n/a 2 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 32
12.15 163.37% 1 Jun 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
n/a n/a 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
1.23 2095.12% 1 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 23
n/a n/a 2 Dec 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
150 140
n/a n/a 7 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
9.34 49.89% 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
60
n/a n/a 6 Nov 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3000 2280
n/a n/a 1 Oct 5, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
25 31
n/a n/a 2 Sep 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 18
n/a n/a 2 Feb 27, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 64
6.58 872.64% 1 Feb 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 22
n/a n/a 2 Oct 9, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
340
22.08 1439.86% 1 Dec 21, 2016